SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Hologic (holx) -- Ignore unavailable to you. Want to Upgrade?

To: Ed Richmond who wrote (388)4/28/1998 7:52:00 PM
From: John Carragher  Respond to of 447
 
that would get it close to my purchase price. John



To: Ed Richmond who wrote (388)4/29/1998 12:13:00 PM
From: ed fowler  Read Replies (1) | Respond to of 447
 
Do you have a copy of that Research Report? Could you post it?

Thanks,
E.



To: Ed Richmond who wrote (388)4/30/1998 1:16:00 AM
From: Ron  Read Replies (2) | Respond to of 447
 
Given that HOLX is in a major product transition...seems the depressed stock price is a buy opportunity? I have read a lot of positive press about Sahara. Won't this be a hot seller to doctors? Can someone
mention where HOLX is in it's roll-out of Sahara? Company release seemed a little vague.
Thanks!
Ron


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News